Literature DB >> 20523235

Comparing alternative methods of targeting potential high-cost individuals for chronic condition management.

David R Anderson1, David J Mangen, Jessica J Grossmeier, Michael J Staufacker, Benjamin J Heinz.   

Abstract

OBJECTIVE: To compare the performance of predictive models based on health care claims, health risk assessment (HRA), or both in prospectively identifying high-cost individuals with chronic conditions.
METHODS: Participants included 8056 employees who completed an HRA and were enrolled in a health plan for at least 6 months during the 36-month study period. Two-stage multivariate regression identified predictors of claims cost in four age-by-gender groups.
RESULTS: All models predicted costs effectively, but the combined model performed better (R2 = 0.198 to 0.309) than either the claims-based (R2 = 0.168 to 0.263) or HRA-based model (R2 = 0.125 to 0.205).
CONCLUSION: An HRA-based predictive model appears to be a reasonable alternative to claims-based predictive models for identifying individuals for chronic condition management outreach. Where practical, a combined model offers advantages of both approaches and meaningfully increases accuracy.

Entities:  

Mesh:

Year:  2010        PMID: 20523235     DOI: 10.1097/JOM.0b013e3181e31792

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  2 in total

1.  Well-being and employee health-how employees' well-being scores interact with demographic factors to influence risk of hospitalization or an emergency room visit.

Authors:  William M Gandy; Carter Coberley; James E Pope; Elizabeth Y Rula
Journal:  Popul Health Manag       Date:  2013-04-05       Impact factor: 2.459

2.  Association of behavioral health factors and social determinants of health with high and persistently high healthcare costs.

Authors:  Stacy Sterling; Felicia Chi; Constance Weisner; Richard Grant; Alix Pruzansky; Sandy Bui; Philip Madvig; Robert Pearl
Journal:  Prev Med Rep       Date:  2018-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.